IrisVision, the leader in digital vision technologies, announced data analytics visionary Narendra Mulani, the founder and formerly Senior managing director of Accenture Applied Intelligence, has joined the company’s board of directors.
A noted advisor, investor and thought leader in AI and advanced analytics, Mulani founded and scaled the Accenture Applied intelligence business from 2012 – 2020. He continues to be active in the AI space, serving on the board of XSell Technologies and Tredence.
Recommended AI News: Anatha Announces Its Accessible, Equitable Public Token Sale Accepting Fiat and Crypto
Mulani also sits on the board of the Seva Foundation, a global non-profit organization that provides eye care services to underserved communities across the globe. Last fall, IrisVision announced a partnership with Seva to help create new technologies to treat vision impairment and prevent blindness in less privileged parts of the world.
Recommended AI News: Ostendio Raises Series A Funding to Expand Its MyVCM Trust Network
“Narendra brings with him valuable experience from his leadership roles at Accenture, Tredence, and Xsell in addition to his amazing work with the Seva Foundation. His excellent leadership and passion for improving healthcare will support IrisVision as we continue to grow and pioneer the future of vision care,” said IrisVision CEO & Co-founder Ammad Khan. “Even before this new role, Narendra has helped me and the team execute our mission to pioneer a new standard of care in vision health. We are all excited to have him guiding our efforts as we grow and scale.”
Narendra noted that he is passionate about IrisVision’s plans “to expand access between patients and their providers and deliver earlier, more frequent insights to address preventable vision loss earlier.” He added, “This is an exciting time in the digital health space and IrisVision is leading the way for remote vision care.”
Recommended AI News: SaaS Startup Synder Raised $2 Million in a Late Seed Round to Revolutionize Accounting for E-Commerce
Comments are closed.